Streamline

This company develops AI-driven automation systems for cell and gene therapy (CGT) manufacturing, improving efficiency and reducing costs. Their flexible, pay-per-use model promotes wider adoption in the industry. Led by experts in AI and life sciences, the company has secured key partnerships and validated its technology, positioning itself as a leader in CGT manufacturing innovation.
由多位AI、機器人技術及細胞基因治療（CGT）領域的專家創立，專注於利用AI驅動的自動化機器人系統解決CGT製造中的瓶頸問題。他們的解決方案能夠提升生產效率，降低成本，並減少人為錯誤，適用於現有的生產線，無需大幅改動。公司採用靈活的商業模式，包括按使用付費，旨在推動CGT行業的自動化進程，讓更多患者能夠更快地獲得生命拯救的治療。這家公司致力於成為CGT製造領域的領導者，推動生命科學的創新發展。